Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Oncocyte Corp (OCX)

6.35 0 (+0.00%)

10/17/2017  4:00pm

Open:

6.35

Pre. Close:

6.35

High:

6.40

Low:

6.17

Volume:

22,027

Market Cap:

198.98M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

6.55 - 7.31

7.31 - 7.89

Low:

5.88 - 6.03

6.03 - 6.13

Close:

6.16 - 6.96

6.96 - 7.56

Technical analysis  (as of: 2017-10-17 4:40:50 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 8.12     One year: 8.92

Support:

Support1: 5.85    Support2: 4.87

Resistance:

Resistance1: 6.96    Resistance2: 7.64

Pivot:

6.68

Moving Averages:

MA(5): 6.66     MA(20): 6.66

MA(100): 5.41     MA(250): 5.63

MACD:

MACD(12,26): 0.15     Signal(12,26,9): 0.24

%K %D:

%K(14,3): 34.45     %D(3): 45.31

RSI:

RSI(14): 49.40

52-Week:

High: 7.95  Low: 3.60  Change(%): 41.5

Average Vol(K):

3-Month: 2493  10-Days 2029

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
OCX has closed above bottom band by 31.9%. Bollinger Bands are 39.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 10 Aug 2017 18:56:15 GMT
Onex Corp's (ONEXF) CEO Gerald Schwartz on Q2 2017 Results - Earnings Call ...

Mon, 17 Oct 2016 11:15:31 GMT
Supervalu to Sell Save-A-Lot Chain to Onex for $1.37 Billion

Thu, 10 Aug 2017 10:52:30 GMT
Onex Reports Second-Quarter 2017 Results

Tue, 08 Nov 2016 21:34:19 GMT
100.62

Thu, 12 Jan 2017 00:11:15 GMT
Exclusive: Onex explores $4 billion sale of USI Insurance Services - sources

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

31.00

Shares Float (M)

4.59

% Held by Insiders

72.68

% Held by Institutions

14.25

Shares Short (K)

197

Shares Short Prior Month (K)

77

Stock Financials

EPS

-0.500

EPS Est. Current Year

-0.540

EPS Est. Next Year

-0.540

EPS Est. Next Quarter

-0.130

Forward EPS

-0.540

Book Value (p.s.)

0.190

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-88.2

Return on Equity (ttm)

-281.1

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.430

Qtrly Earnings Growth

Operating Cash Flow (M)

-10.12

Levered Free Cash Flow (M)

-6.14

FoxReading.com

Valuation

P/E

-12.70

P/E Growth Ratio

P/BV

33.42

P/S

P/CF

-19.45

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.